期刊文献+

Transcription Factors:Potential Cell Death Markers in Parkinson's Disease 被引量:5

Transcription Factors: Potential Cell Death Markers in Parkinson's Disease
原文传递
导出
摘要 Parkinson's disease (PD) is a neurodegenerative disease with a long preclinical phase. The continuous loss of dopaminergic (DA) neurons is one of the pathogenic hallmarks of PD. Diagnosis largely depends on clinical observation, but motor dysfunctions do not emerge until 70%-80% of the nigrostriatal nerve terminals have been destroyed. Therefore, a biomarker that indicates the degeneration of DA neurons is urgently needed. Transcrip- tion factors are sequence-specific DNA-binding proteins that regulate RNA synthesis from a DNA template. The precise control of gene expression plays a critical role in the development, maintenance, and survival of cells, including DA neurons. Deficiency of certain transcription factors has been associated with DA neuron loss and PD. In this review, we focus on some transcription factors and discuss their structure, function, mechanisms of neuropro- tection, and their potential for use as biomarkers indicating the degeneration of DA neurons. Parkinson's disease (PD) is a neurodegenerative disease with a long preclinical phase. The continuous loss of dopaminergic (DA) neurons is one of the pathogenic hallmarks of PD. Diagnosis largely depends on clinical observation, but motor dysfunctions do not emerge until 70%-80% of the nigrostriatal nerve terminals have been destroyed. Therefore, a biomarker that indicates the degeneration of DA neurons is urgently needed. Transcrip- tion factors are sequence-specific DNA-binding proteins that regulate RNA synthesis from a DNA template. The precise control of gene expression plays a critical role in the development, maintenance, and survival of cells, including DA neurons. Deficiency of certain transcription factors has been associated with DA neuron loss and PD. In this review, we focus on some transcription factors and discuss their structure, function, mechanisms of neuropro- tection, and their potential for use as biomarkers indicating the degeneration of DA neurons.
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2017年第5期552-560,共9页 神经科学通报(英文版)
基金 supported by the National Key Research and Development Program of China (2016YFC1306603) the National Natural Science Foundation of China (31671060)
关键词 Parkinson's disease · Transcription factor -Biomarker · Cell death · Dopaminergic neuron Parkinson's disease · Transcription factor -Biomarker · Cell death · Dopaminergic neuron
  • 相关文献

参考文献5

二级参考文献87

  • 1[74]Heath PR and Shaw PJ. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26:438-58.
  • 2[75]Simpson EP, Yen AA, Appel SH. Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.Curr Opin Rheumatol. 2003; 15(6):730-6.
  • 3[76]Munch C, Ebstein M, Seefried U, et al. Alternative splicing of the 5′-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.J Neurochem 2002; 82:594-603.
  • 4[77]Schuff N, Rooney WD, Miller R, et al. Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med 2001; 45: 513-6.
  • 5[78]Reddy PH, Williams M, Tagle DA. Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci 1999; 22:248-55.
  • 6[79]Caramins M, Halliday G, McCusker E, and Trent RJ. Genetically confirmed clinical Huntington's disease with no observable cell loss. J Neurol Neurosurg Psychiatry 2003; 74:968-70.
  • 7[80]Law HY, Ng IS, Yoon CS, et al. Trinucleotide repeat analysis of Huntington's disease gene in Singapore; Ann Acad Med Singapore. 2001; 30(2): 122-7.
  • 8[81]Langbehn D, Brinkman R, Falush D, et al. On behalf of an International Huntington's Disease Collaborative Group dagger. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65(4):267-77.
  • 9[82]Hsu YY, Du AT, Schuff N, and Weiner MW. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.J Geriatr Psychiatry Neurol 2001; 14:145-66.
  • 10[83]Reynolds NC Jr, Hellman RS, Tikofsky RS, et al. Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington' s disease. Nucl Med Commun 2002; 23:13-8.

共引文献36

同被引文献44

引证文献5

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部